UBS Group’s Nuvation Bio NUVB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $924K | Sell |
473,939
-397,753
| -46% | -$776K | ﹤0.01% | 4410 |
|
|
2025
Q1 | $1.53M | Sell |
871,692
-979,001
| -53% | -$1.72M | ﹤0.01% | 3872 |
|
|
2024
Q4 | $4.92M | Buy |
1,850,693
+1,385,584
| +298% | +$3.69M | ﹤0.01% | 3013 |
|
|
2024
Q3 | $1.07M | Buy |
465,109
+65,526
| +16% | +$150K | ﹤0.01% | 3535 |
|
|
2024
Q2 | $1.17M | Sell |
399,583
-24,219
| -6% | -$70.7K | ﹤0.01% | 3271 |
|
|
2024
Q1 | $1.54M | Buy |
423,802
+42,483
| +11% | +$155K | ﹤0.01% | 3200 |
|
|
2023
Q4 | $576K | Buy |
381,319
+285,713
| +299% | +$431K | ﹤0.01% | 3875 |
|
|
2023
Q3 | $128K | Buy |
95,606
+285
| +0.3% | +$382 | ﹤0.01% | 4565 |
|
|
2023
Q2 | $172K | Sell |
95,321
-15,033
| -14% | -$27.1K | ﹤0.01% | 4553 |
|
|
2023
Q1 | $183K | Buy |
+110,354
| New | +$183K | ﹤0.01% | 4407 |
|
|
2022
Q4 | – | Sell |
-5,620
| Closed | -$13K | – | 9712 |
|
|
2022
Q3 | $13K | Buy |
5,620
+3,024
| +116% | +$7K | ﹤0.01% | 6952 |
|
|
2022
Q2 | $8K | Buy |
2,596
+2,560
| +7,111% | +$7.89K | ﹤0.01% | 7286 |
|
|
2022
Q1 | $0 | Sell |
36
-473
| -93% | – | ﹤0.01% | 9462 |
|
|
2021
Q4 | $4K | Buy |
509
+422
| +485% | +$3.32K | ﹤0.01% | 8409 |
|
|
2021
Q3 | $1K | Buy |
87
+20
| +30% | +$230 | ﹤0.01% | 8057 |
|
|
2021
Q2 | $1K | Sell |
67
-1,996
| -97% | -$29.8K | ﹤0.01% | 8057 |
|
|
2021
Q1 | $22K | Sell |
2,063
-769
| -27% | -$8.2K | ﹤0.01% | 6274 |
|
|
2020
Q4 | $33K | Buy |
+2,832
| New | +$33K | ﹤0.01% | 5554 |
|